Kodiak Sciences IncNASDAQ:KOD
- LAST PRICE2.3700
- TODAY'S CHANGE (%)0.0200 (0.8511%)
- Bid / Lots2.3100/ 1
- Ask / Lots2.4200/ 1
- Open / Previous Close2.3900 / 2.3500
- Day Range
- 52 Week Range
- Volume238,269
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | KOD |
|---|---|---|
| 09:32 ET | 5142 | 2.42 |
| 09:34 ET | 300 | 2.38 |
| 09:38 ET | 773 | 2.4 |
| 09:41 ET | 200 | 2.39 |
| 09:45 ET | 668 | 2.375 |
| 09:50 ET | 700 | 2.39 |
| 09:54 ET | 112 | 2.39 |
| 09:56 ET | 200 | 2.41 |
| 09:57 ET | 100 | 2.41 |
| 10:01 ET | 517 | 2.43 |
| 10:03 ET | 400 | 2.43 |
| 10:06 ET | 2020 | 2.42 |
| 10:08 ET | 300 | 2.42 |
| 10:12 ET | 1645 | 2.405 |
| 10:14 ET | 400 | 2.395 |
| 10:15 ET | 1276 | 2.38 |
| 10:17 ET | 400 | 2.38 |
| 10:19 ET | 600 | 2.38 |
| 10:21 ET | 200 | 2.39 |
| 10:24 ET | 810 | 2.38 |
| 10:26 ET | 500 | 2.38 |
| 10:28 ET | 200 | 2.38 |
| 10:30 ET | 408 | 2.38 |
| 10:32 ET | 1204 | 2.37 |
| 10:33 ET | 400 | 2.37 |
| 10:35 ET | 400 | 2.37 |
| 10:37 ET | 100 | 2.365 |
| 10:39 ET | 100 | 2.365 |
| 10:42 ET | 300 | 2.365 |
| 10:44 ET | 820 | 2.365 |
| 10:46 ET | 7192 | 2.36 |
| 10:48 ET | 100 | 2.355 |
| 10:50 ET | 699 | 2.355 |
| 10:53 ET | 2900 | 2.355 |
| 10:55 ET | 1300 | 2.355 |
| 10:57 ET | 800 | 2.355 |
| 11:00 ET | 100 | 2.355 |
| 11:02 ET | 7807 | 2.37 |
| 11:04 ET | 2300 | 2.365 |
| 11:06 ET | 2198 | 2.36 |
| 11:08 ET | 1693 | 2.37 |
| 11:13 ET | 356 | 2.37 |
| 11:15 ET | 100 | 2.37 |
| 11:18 ET | 600 | 2.365 |
| 11:20 ET | 100 | 2.365 |
| 11:22 ET | 300 | 2.36 |
| 11:24 ET | 900 | 2.36 |
| 11:26 ET | 300 | 2.36 |
| 11:27 ET | 200 | 2.35 |
| 11:29 ET | 600 | 2.355 |
| 11:31 ET | 600 | 2.35 |
| 11:33 ET | 620 | 2.34 |
| 11:36 ET | 100 | 2.345 |
| 11:38 ET | 300 | 2.345 |
| 11:40 ET | 200 | 2.34 |
| 11:42 ET | 200 | 2.345 |
| 11:44 ET | 415 | 2.335 |
| 11:45 ET | 100 | 2.34 |
| 11:47 ET | 200 | 2.335 |
| 11:49 ET | 800 | 2.325 |
| 11:51 ET | 1103 | 2.33 |
| 11:56 ET | 100 | 2.33 |
| 12:00 ET | 2800 | 2.35 |
| 12:02 ET | 200 | 2.34 |
| 12:03 ET | 800 | 2.34 |
| 12:07 ET | 419 | 2.3499 |
| 12:09 ET | 100 | 2.34 |
| 12:12 ET | 100 | 2.34 |
| 12:14 ET | 200 | 2.33 |
| 12:18 ET | 100 | 2.34 |
| 12:23 ET | 100 | 2.34 |
| 12:25 ET | 500 | 2.33 |
| 12:27 ET | 500 | 2.335 |
| 12:32 ET | 100 | 2.335 |
| 12:38 ET | 100 | 2.335 |
| 12:43 ET | 100 | 2.335 |
| 12:48 ET | 100 | 2.335 |
| 12:50 ET | 1016 | 2.33 |
| 12:52 ET | 100 | 2.33 |
| 12:54 ET | 404 | 2.33 |
| 12:56 ET | 115 | 2.33 |
| 12:57 ET | 300 | 2.33 |
| 12:59 ET | 100 | 2.33 |
| 01:01 ET | 100 | 2.33 |
| 01:03 ET | 2387 | 2.31 |
| 01:06 ET | 300 | 2.31 |
| 01:08 ET | 100 | 2.32 |
| 01:12 ET | 300 | 2.33 |
| 01:15 ET | 100 | 2.32 |
| 01:17 ET | 319 | 2.32 |
| 01:21 ET | 400 | 2.32 |
| 01:28 ET | 300 | 2.33 |
| 01:30 ET | 100 | 2.32 |
| 01:33 ET | 400 | 2.32 |
| 01:37 ET | 300 | 2.33 |
| 01:39 ET | 500 | 2.33 |
| 01:42 ET | 612 | 2.315 |
| 01:44 ET | 400 | 2.31 |
| 01:46 ET | 200 | 2.31 |
| 01:48 ET | 100 | 2.31 |
| 01:50 ET | 100 | 2.31 |
| 01:55 ET | 600 | 2.31 |
| 01:57 ET | 100 | 2.31 |
| 02:00 ET | 100 | 2.31 |
| 02:04 ET | 300 | 2.31 |
| 02:09 ET | 1200 | 2.32 |
| 02:11 ET | 500 | 2.315 |
| 02:13 ET | 500 | 2.3146 |
| 02:18 ET | 3368 | 2.325 |
| 02:22 ET | 100 | 2.325 |
| 02:26 ET | 214 | 2.326 |
| 02:27 ET | 300 | 2.325 |
| 02:29 ET | 100 | 2.33 |
| 02:31 ET | 400 | 2.335 |
| 02:45 ET | 100 | 2.335 |
| 02:47 ET | 300 | 2.335 |
| 02:49 ET | 100 | 2.335 |
| 02:51 ET | 121 | 2.335 |
| 02:54 ET | 350 | 2.335 |
| 02:58 ET | 1416 | 2.325 |
| 03:00 ET | 166 | 2.325 |
| 03:02 ET | 1882 | 2.325 |
| 03:05 ET | 100 | 2.325 |
| 03:07 ET | 100 | 2.325 |
| 03:09 ET | 200 | 2.325 |
| 03:14 ET | 1632 | 2.325 |
| 03:16 ET | 1922 | 2.32 |
| 03:18 ET | 100 | 2.32 |
| 03:20 ET | 675 | 2.315 |
| 03:21 ET | 200 | 2.315 |
| 03:23 ET | 300 | 2.315 |
| 03:25 ET | 300 | 2.315 |
| 03:27 ET | 300 | 2.315 |
| 03:30 ET | 100 | 2.315 |
| 03:32 ET | 200 | 2.315 |
| 03:34 ET | 2254 | 2.32 |
| 03:38 ET | 1200 | 2.34 |
| 03:39 ET | 105 | 2.3301 |
| 03:41 ET | 1150 | 2.335 |
| 03:43 ET | 510 | 2.335 |
| 03:45 ET | 500 | 2.335 |
| 03:48 ET | 800 | 2.335 |
| 03:50 ET | 600 | 2.335 |
| 03:52 ET | 100 | 2.335 |
| 03:54 ET | 1600 | 2.34 |
| 03:56 ET | 11062 | 2.355 |
| 03:57 ET | 9899 | 2.36 |
| 03:59 ET | 40304 | 2.37 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Kodiak Sciences Inc | 123.5M | -0.5x | --- |
Tevogen Bio Holdings Inc | 120.1M | -1,702.3x | --- |
Regulus Therapeutics Inc | 116.9M | -1.3x | --- |
Nuvectis Pharma Inc | 116.2M | -4.4x | --- |
Invivyd Inc | 131.2M | -0.6x | --- |
Corvus Pharmaceuticals Inc | 113.8M | -3.6x | --- |
Company Information
Kodiak Sciences Inc. is a biopharmaceutical company. The Company has developed a new technology platform, the Antibody Biopolymer Conjugate (ABC) Platform, for retinal medicines. Its ABC Platform uses molecular engineering to merge the fields of protein-based and chemistry-based therapies. Its lead investigational medicine, tarcocimab, is a novel anti-vascular endothelial growth factor (anti-VEGF) antibody biopolymer conjugate under development for the treatment of high prevalence retinal vascular diseases, including diabetic retinopathy, the cause of blindness in working-age patients in the developed world, and wet age-related macular degeneration, the cause of blindness in elderly patients. Its second investigational medicine, KSI-501, is a bispecific antibody biopolymer conjugate targeting the pro-inflammatory cytokine interleukin-6 (IL-6) and VEGF. It is also developing a third investigational medicine, KSI-101, an unconjugated bispecific protein targeting IL-6 and VEGF.
Contact Information
- Headquarters
- 1200 PAGE MILL RDPALO ALTO, CA, United States 94304
- Phone
- 650-281-0850
- Fax
- 302-636-5454
Executives
- Chairman of the Board, Chief Executive Officer, Co-Founder
- Victor Perlroth
- Chief Financial Officer, Executive Vice President, Secretary
- John Borgeson
- Lead Independent Director
- Robert Profusek
- Independent Director
- Felix Baker
- Independent Director
- Charles Bancroft
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $123.5M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 52.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.36 |
EPS | $-4.44 |
Book Value | $5.06 |
P/E Ratio | -0.5x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
